RDHL - Redhill Biopharma Lt...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $9.94 | Open | |
| Volume | Market Cap | 424.6M | |
| Yield | Last Dividend |
| RedHill Biopharma Expands Opaganib Globa... | 02/23/21 |
| Following the FDA review of data from the U.S. Phase 2 study of opaganib and receipt of its recommendations, RedHill Biopharma Ltd (NASDAQ: RDHL) plan... | |
| The Daily Biotech Pulse: Aridis To Study... | 02/23/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 22) Acc... | |
| RedHill Biopharma Strengthens Partnershi... | 02/18/21 |
| TEL AVIV, Israel and RALEIGH, N.C., Feb. 18, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma to Present at SVB Leer... | 02/09/21 |
| TEL AVIV, Israel and RALEIGH, N.C., Feb. 9, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty bioph... | |
| RedHill Biopharma Announces Positive DSM... | 01/29/21 |
| TEL AVIV, Israel and RALEIGH, N.C., Jan. 29, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma Increases Previously A... | 01/12/21 |
| TEL AVIV, Israel and RALEIGH, N.C., Jan. 12, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma Announces $10 Million ... | 01/11/21 |
| TEL AVIV, Israel and RALEIGH, N.C., Jan. 11, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill's Partner Cosmo Pharmaceuticals ... | 01/11/21 |
| TEL AVIV, Israel and RALEIGH, N.C,, Jan. 11, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or "the Company"), a specialty biop... | |
| Biopharma Daily Stock Updates - 01/06/20 | 01/06/21 |
| $XBI $143.32 (+2.04%) ???? PIPELINE: $IMRA (-37.97%) - Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Dis... | |
| RedHill Biopharma's RHB-204 Granted FDA ... | 01/06/21 |
| TEL AVIV, Israel and RALEIGH, NC, Jan. 6, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or "the Company"), a specialty biophar... | |
| RedHill Biopharma Ltd. said that prelimi... | 01/02/21 |
| RedHill Biopharma Ltd. said that preliminary data results from the US Phase 2 study of its opaganib administered in patients hospitalized with COVID-1... | |
| RedHill Biopharma Announces Positive Top... | 12/31/20 |
| It's what's happening in business. | |
| FXNEWS24 |Is the Options Market Predicti... | 12/28/20 |
| Is the Options Market Predicting a Spike in RedHill Biopharma (RDHL) Stock? | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex New... | |
| RedHill's Phase 2/3 COVID-19 Candidate O... | 12/15/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Dec. 15, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma Extends Talicia?? Unre... | 12/07/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Dec. 7, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty bioph... | |
| RedHill Biopharma to Present at Evercore... | 11/23/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Nov. 23, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma Initiates Phase 3 Stud... | 11/20/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Nov. 20, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or "the Company"), a specialty biop... | |
| RedHill Announces Unanimous DSMB Recomme... | 11/19/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Nov. 19, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| Zacks Investment Research Lowers RedHill... | 11/18/20 |
| Zacks Investment Research downgraded shares of RedHill Biopharma (NASDAQ:RDHL) from a hold rating to a sell rating in a report released on Saturday, Z... | |
| RedHill Biopharma's Second COVID-19 Cand... | 11/17/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Nov. 17, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| Earnings Scheduled For November 12, 2020... | 11/12/20 |
| Companies Reporting Before The Bell ??? Redhill Biopharma (NASDAQ:RDHL) is projected to report quarterly loss at $0.16 per share on revenue of $25.37 ... | |
| Earnings Scheduled For November 12, 2020 | 11/11/20 |
| Companies Reporting Before The Bell ??? Redhill Biopharma (NASDAQ:RDHL) is projected to report quarterly loss at $0.16 per share on revenue of ??? | |
| Short Interest in RedHill Biopharma Ltd.... | 10/20/20 |
| RedHill Biopharma Ltd. (NASDAQ:RDHL) saw a large decline in short interest during the month of September. As of September 30th, there was short intere... | |
| RedHill Biopharma Ltd. (NASDAQ:RDHL) Sho... | 10/19/20 |
| RedHill Biopharma Ltd. (NASDAQ:RDHL) saw a significant decrease in short interest during the month of September. As of September 30th, there was short... | |
| RedHill Biopharma Announces FDA Orphan D... | 10/14/20 |
| RHB-204 Phase 3 study in pulmonary NTM infections is planned to be initiated in the coming weeks--Orphan Drug Designation, along with RHB-204???s FDA ... | |
| RedHill Biopharma announces partnership ... | 10/13/20 |
| RedHill Biopharma (RDHL +1.3%) collaborates with European and Canadian suppliers to ramp-up manufacturing of COVID-19 therapeutic candidate, opaganib,... | |
| RedHill Biopharma Announces Partnerships... | 10/13/20 |
| Collaborations with European and Canadian suppliers for large-scale ramp-up of opaganib manufacturing further strengthens manufacturing??? | |
| FXNEWS24 |BUZZ-U.S. STOCKS ON THE MOVE-W... | 10/07/20 |
| BUZZ-U.S. STOCKS ON THE MOVE-Workday, Stable Road Acquisition, RedHill Biopharma, Fox Corp, Disney | UK Stocks, Forex, Commodities, Crypto, Live Marke... | |
| Veeva partners with RedHill Bio to advan... | 09/23/20 |
| Veeva Systems (NYSE:VEEV) and Bioforum collaborates with RedHill Biopharma (NASDAQ:RDHL) on a global Phase 2/3 clinical study evaluating opaganib (Yel... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
